Oxis biotech names new CFO
This article was originally published in Scrip
Oxis Biotech, a subsidiary of Oxis International, has appointed of Steven Weldon chief financial officer, chief accounting officer and a member of its board of directors. A certified public accountant licensed to practice in the state of Florida, Mr Weldon has more than 15 years' experience working with public and private firms.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.